| 1 | Incyte Corporation US45337C1027 | 🇺🇸 US | $25,0 Mrd. | A+ |
| 2 | Catalyst Pharmaceuticals Inc. US14888U1016 | 🇺🇸 US | $3,9 Mrd. | A+ |
| 3 | Exelixis Inc. US30161Q1040 | 🇺🇸 US | $12,9 Mrd. | A+ |
| 4 | United Therapeutics Corporation US91307C1027 | 🇺🇸 US | $21,2 Mrd. | A+ |
| 5 | Ligand Pharmaceuticals Incorporated US53220K5048 | 🇺🇸 US | $5,8 Mrd. | A+ |
| 6 | Anthem Biosciences Ltd. INE0CZ201020 | 🇮🇳 IN | $5,3 Mrd. | A+ |
| 7 | Halozyme Therapeutics Inc. US40637H1095 | 🇺🇸 US | $11,7 Mrd. | A+ |
| 8 | Regeneron Pharmaceuticals Inc. US75886F1075 | 🇺🇸 US | $83,0 Mrd. | A+ |
| 9 | Vertex Pharmaceuticals Incorporated US92532F1003 | 🇺🇸 US | $128,4 Mrd. | A+ |
| 10 | Neurocrine Biosciences Inc. US64125C1099 | 🇺🇸 US | $15,5 Mrd. | A+ |
| 11 | Rigel Pharmaceuticals Inc. US7665597024 | 🇺🇸 US | $785 Mio. | A+ |
| 12 | WuXi Biologics (Cayman) Inc. KYG970081173 | 🇨🇳 CN | $24,4 Mrd. | A+ |
| 13 | ACADIA Pharmaceuticals Inc. US0042251084 | 🇺🇸 US | $5,0 Mrd. | A+ |
| 14 | Harmony Biosciences Holdings Inc. US4131971040 | 🇺🇸 US | $2,2 Mrd. | A+ |
| 15 | argenx SE NL0010832176 | 🇳🇱 NL | $61,6 Mrd. | A+ |
| 16 | ALK-Abelló A/S DK0061802139 | 🇩🇰 DK | $7,5 Mrd. | A+ |
| 17 | Ascendis Pharma A/S DK0060615755 | 🇩🇰 DK | $15,4 Mrd. | A+ |
| 18 | TG Therapeutics Inc. US88322Q1085 | 🇺🇸 US | $7,5 Mrd. | A+ |
| 19 | Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd CNE1000062X2 | 🇨🇳 CN | $6,5 Mrd. | A+ |
| 20 | Shanghai Allist Pharmaceuticals Co. Ltd. CNE100005XJ7 | 🇨🇳 CN | $8,0 Mrd. | A+ |
| 21 | Pharmaron Beijing Co. Ltd. CNE100003JW4 | 🇨🇳 CN | $11,0 Mrd. | A+ |
| 22 | Krystal Biotech Inc. US5011471027 | 🇺🇸 US | $9,9 Mrd. | A |
| 23 | UCB S.A. BE0003739530 | 🇧🇪 BE | $48,1 Mrd. | A |
| 24 | BeOne Medicines AG CH1391448177 | 🇨🇭 CH | $36,3 Mrd. | A |
| 25 | BeOne Medicines Ltd. Class A CNE100005XT6 | 🇨🇭 CH | $45,0 Mrd. | A |
| 26 | Lakefront Biotherapeutics BE0003818359 | 🇧🇪 BE | $2,0 Mrd. | A |
| 27 | Aurinia Pharmaceuticals Inc. CA05156V1022 | 🇨🇦 CA | $2,0 Mrd. | A |
| 28 | Jazz Pharmaceuticals plc IE00B4Q5ZN47 | 🇮🇪 IE | $15,6 Mrd. | A |
| 29 | Bio-Techne Corporation US09073M1045 | 🇺🇸 US | $11,3 Mrd. | A |
| 30 | Alkermes plc IE00B56GVS15 | 🇮🇪 IE | $8,4 Mrd. | A |
| 31 | Simcere Pharmaceutical Group Limited HK0000658531 | 🇨🇳 CN | $4,0 Mrd. | A |
| 32 | DaShenLin Pharmaceutical Group Co. Ltd. CNE100002RG2 | 🇨🇳 CN | $3,0 Mrd. | A |
| 33 | Bachem Holding AG CH1176493729 | 🇨🇭 CH | $6,9 Mrd. | A |
| 34 | Innoviva Inc. US45781M1018 | 🇺🇸 US | $1,5 Mrd. | A |
| 35 | Gubra A/S DK0062266474 | 🇩🇰 DK | $946 Mio. | A |
| 36 | Sichuan Kelun Pharmaceutical Co. Ltd. Class A CNE100000PW7 | 🇨🇳 CN | $11,0 Mrd. | B+ |
| 37 | MeiraGTx Holdings plc KYG596651029 | 🇺🇸 US | $1,3 Mrd. | B+ |
| 38 | Asymchem Laboratories (Tianjin) Co. Ltd. CNE100002BZ6 | 🇨🇳 CN | $8,8 Mrd. | B+ |
| 39 | Celltrion Inc. KR7068270008 | 🇰🇷 KR | $31,9 Mrd. | B+ |
| 40 | Samsung Biologics Co.Ltd. KR7207940008 | 🇰🇷 KR | $49,8 Mrd. | B+ |
| 41 | Arcutis Biotherapeutics Inc. US03969K1088 | 🇺🇸 US | $3,2 Mrd. | B+ |
| 42 | Neuren Pharmaceuticals Limited NZNEUE0001S8 | 🇦🇺 AU | $2,1 Mrd. | B+ |
| 43 | Genmab A/S DK0010272202 | 🇩🇰 DK | $19,3 Mrd. | B+ |
| 44 | Camurus AB SE0007692850 | 🇸🇪 SE | $3,8 Mrd. | B+ |
| 45 | Omeros Corporation US6821431029 | 🇺🇸 US | $1,3 Mrd. | B+ |
| 46 | Vericel Corporation US92346J1088 | 🇺🇸 US | $2,3 Mrd. | B+ |
| 47 | BioMarin Pharmaceutical Inc. US09061G1013 | 🇺🇸 US | $12,9 Mrd. | B+ |
| 48 | Travere Therapeutics Inc. US89422G1076 | 🇺🇸 US | $5,8 Mrd. | B+ |
| 49 | Biocytogen Pharmaceuticals (Beijing) Co. Ltd. CNE100005D27 | 🇨🇳 CN | $3,3 Mrd. | B |
| 50 | Innovent Biologics Inc. KYG4818G1010 | 🇨🇳 CN | $21,2 Mrd. | B |
| 51 | 3SBio Inc. KYG8875G1029 | 🇨🇳 CN | $5,6 Mrd. | B |
| 52 | Lonza Group AG CH0013841017 | 🇨🇭 CH | $48,8 Mrd. | B |
| 53 | Compugen Ltd. IL0010852080 | 🇮🇱 IL | $222 Mio. | B |
| 54 | Axsome Therapeutics Inc. US05464T1043 | 🇺🇸 US | $11,1 Mrd. | B |
| 55 | CSL Limited AU000000CSL8 | 🇦🇺 AU | $46,4 Mrd. | B |
| 56 | BioArctic AB SE0010323311 | 🇸🇪 SE | $3,0 Mrd. | B |
| 57 | Clinuvel Pharmaceuticals Limited AU000000CUV3 | 🇦🇺 AU | $340 Mio. | B |
| 58 | Biocon Limited INE376G01013 | 🇮🇳 IN | $5,9 Mrd. | B |
| 59 | BridgeBio Pharma Inc. US10806X1028 | 🇺🇸 US | $15,6 Mrd. | B |
| 60 | Alteogen Inc. KR7196170005 | 🇰🇷 KR | $15,0 Mrd. | B |
| 61 | Zevra Therapeutics Inc. US4884452065 | 🇺🇸 US | $669 Mio. | B |
| 62 | InnoCare Pharma Limited KYG4783B1032 | 🇨🇳 CN | $2,8 Mrd. | B |
| 63 | Bavarian Nordic A/S DK0015998017 | 🇩🇰 DK | $2,2 Mrd. | B |
| 64 | Xiamen Amoytop Biotech Co. Ltd. CNE100003RT3 | 🇨🇳 CN | $3,5 Mrd. | B |
| 65 | Suzhou Zelgen Biopharmaceuticals Co. Ltd. CNE100003RP1 | 🇨🇳 CN | $4,8 Mrd. | B |
| 66 | Alnylam Pharmaceuticals Inc. US02043Q1076 | 🇺🇸 US | $30,1 Mrd. | B |
| 67 | UroGen Pharma Ltd. IL0011407140 | 🇺🇸 US | $2,3 Mrd. | B |
| 68 | Anhui Anke Biotechnology (Group) Co. Ltd. CNE100000GY2 | 🇨🇳 CN | $2,2 Mrd. | C |
| 69 | Haisco Pharmaceutical Group Co. Ltd. CNE100001BC7 | 🇨🇳 CN | $11,7 Mrd. | C |
| 70 | Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. CNE1000062J1 | 🇨🇳 CN | $15,5 Mrd. | C |
| 71 | SK Biopharmaceuticals Co. Ltd. KR7326030004 | 🇰🇷 KR | $4,8 Mrd. | C |
| 72 | Hugel Inc. KR7145020004 | 🇰🇷 KR | $1,9 Mrd. | C |
| 73 | AnaptysBio Inc. US0327241065 | 🇺🇸 US | $1,8 Mrd. | C |
| 74 | Adaptive Biotechnologies Corporation US00650F1093 | 🇺🇸 US | $4,0 Mrd. | C |
| 75 | ADMA Biologics Inc. US0008991046 | 🇺🇸 US | $2,2 Mrd. | C |
| 76 | Madrigal Pharmaceuticals Inc. US5588681057 | 🇺🇸 US | $12,1 Mrd. | C |
| 77 | Beijing Tiantan Biological Products Co. Ltd. CNE000000WF9 | 🇨🇳 CN | $3,6 Mrd. | C |
| 78 | Puma Biotechnology Inc. US74587V1070 | 🇺🇸 US | $449 Mio. | C |
| 79 | Rhythm Pharmaceuticals Inc. US76243J1051 | 🇺🇸 US | $7,9 Mrd. | C |
| 80 | Xeris Biopharma Holdings Inc. US98422E1038 | 🇺🇸 US | $1,5 Mrd. | C |
| 81 | PTC Therapeutics Inc. US69366J2006 | 🇺🇸 US | $6,1 Mrd. | C |
| 82 | PharmaEngine Inc. TW0004162003 | 🇹🇼 TW | $267 Mio. | C |
| 83 | Protagonist Therapeutics Inc. US74366E1029 | 🇺🇸 US | $10,2 Mrd. | C |
| 84 | Pharma Mar S.A. ES0169501022 | 🇪🇸 ES | $1,7 Mrd. | C |
| 85 | Basilea Pharmaceutica AG CH0011432447 | 🇨🇭 CH | $827 Mio. | C |
| 86 | Telix Pharmaceuticals Limited AU000000TLX2 | 🇦🇺 AU | $4,0 Mrd. | C |
| 87 | Shanghai RAAS Blood Products Co. Ltd. CNE100000C31 | 🇨🇳 CN | $4,8 Mrd. | C |
| 88 | Hualan Biological Engineering Inc. CNE000001JN8 | 🇨🇳 CN | $3,6 Mrd. | C |
| 89 | CorMedix Inc. US21900C3088 | 🇺🇸 US | $592 Mio. | C |
| 90 | RemeGen Co. Ltd. Class A CNE100005B03 | 🇨🇳 CN | $11,0 Mrd. | C |
| 91 | ImmunityBio Inc. US45256X1037 | 🇺🇸 US | $8,3 Mrd. | C |
| 92 | Caris Life Sciences Inc. US1421521071 | 🇺🇸 US | $6,1 Mrd. | C |
| 93 | Iovance Biotherapeutics Inc. US4622601007 | 🇺🇸 US | $3,2 Mrd. | C |
| 94 | HBM Holdings Limited KYG4403H1002 | 🇨🇳 CN | $1,6 Mrd. | C |
| 95 | Genscript Biotech Corporation KYG3825B1059 | 🇭🇰 HK | $7,3 Mrd. | C |
| 96 | Zealand Pharma A/S DK0060257814 | 🇩🇰 DK | $3,4 Mrd. | C |
| 97 | Arbutus Biopharma Corp CA03879J1003 | 🇺🇸 US | $930 Mio. | C |
| 98 | Crinetics Pharmaceuticals Inc. US22663K1079 | 🇺🇸 US | $9,0 Mrd. | C |
| 99 | Genus plc GB0002074580 | 🇬🇧 GB | $2,0 Mrd. | C |
| 100 | Praxis Precision Medicines Inc. US74006W2070 | 🇺🇸 US | $10,5 Mrd. | C |
| 101 | Tarsus Pharmaceuticals Inc. US87650L1035 | 🇺🇸 US | $3,0 Mrd. | C |
| 102 | Moderna Inc. US60770K1079 | 🇺🇸 US | $25,6 Mrd. | C |
| 103 | MiMedx Group Inc. US6024961012 | 🇺🇸 US | $611 Mio. | C |
| 104 | Mirum Pharmaceuticals Inc. US6047491013 | 🇺🇸 US | $6,1 Mrd. | C |
| 105 | Hangzhou Tigermed Consulting Co. Ltd CNE1000040M1 | 🇨🇳 CN | $6,4 Mrd. | C |
| 106 | CG Oncology Inc. US1569441009 | 🇺🇸 US | $6,8 Mrd. | C |
| 107 | Vaxcyte Inc. US92243G1085 | 🇺🇸 US | $8,7 Mrd. | C |
| 108 | Roivant Sciences Ltd. BMG762791017 | 🇬🇧 GB | $26,2 Mrd. | C |
| 109 | Theravance Biopharma Inc KYG8807B1068 | 🇺🇸 US | $880 Mio. | C |
| 110 | Concord Biotech Limited INE338H01029 | 🇮🇳 IN | $1,6 Mrd. | C |
| 111 | Kuros Biosciences AG CH0325814116 | 🇨🇭 CH | $1,0 Mrd. | C |
| 112 | Syngene International Limited INE398R01022 | 🇮🇳 IN | $1,7 Mrd. | C |
| 113 | Fennec Pharmaceuticals Inc. CA31447P1009 | 🇺🇸 US | $444 Mio. | D |
| 114 | Idorsia Ltd CH0363463438 | 🇨🇭 CH | $1,9 Mrd. | D |
| 115 | BioCryst Pharmaceuticals Inc. US09058V1035 | 🇺🇸 US | $2,5 Mrd. | D |
| 116 | Protalix BioTherapeutics Inc. US74365A3095 | 🇺🇸 US | $185 Mio. | D |
| 117 | Nurix Therapeutics Inc. US67080M1036 | 🇺🇸 US | $2,8 Mrd. | D |
| 118 | XtalPi Holdings Ltd KYG7S12M1051 | 🇨🇳 CN | $4,3 Mrd. | D |
| 119 | Shanghai Junshi Biosciences Co. Ltd. CNE1000041Z1 | 🇨🇳 CN | $5,9 Mrd. | D |
| 120 | Pharmicell Co. Ltd. KR7005690003 | 🇰🇷 KR | $504 Mio. | D |
| 121 | Nanobiotix S.A. FR0011341205 | 🇫🇷 FR | $2,1 Mrd. | D |
| 122 | Alumis Inc. US0223071020 | 🇺🇸 US | $3,1 Mrd. | D |
| 123 | IDEAYA Biosciences Inc. US45166A1025 | 🇺🇸 US | $3,5 Mrd. | D |
| 124 | Cytokinetics Incorporated US23282W6057 | 🇺🇸 US | $9,2 Mrd. | D |
| 125 | Onesource Specialty Pharma Ltd. INE013P01021 | 🇮🇳 IN | $1,9 Mrd. | D |
| 126 | Fortrea Holdings Inc. US34965K1079 | 🇺🇸 US | $1,7 Mrd. | D |
| 127 | Edgewise Therapeutics Inc. US28036F1057 | 🇺🇸 US | $4,8 Mrd. | D |
| 128 | Immunovant Inc. US45258J1025 | 🇺🇸 US | $9,0 Mrd. | D |
| 129 | Palvella Therapeutics Inc. US6979471090 | 🇺🇸 US | $2,2 Mrd. | D |
| 130 | Insmed Incorporated US4576693075 | 🇺🇸 US | $27,8 Mrd. | D |
| 131 | Ionis Pharmaceuticals Inc. US4622221004 | 🇺🇸 US | $9,7 Mrd. | D |
| 132 | Lepu Biopharma Co. Ltd. CNE100004SM4 | 🇨🇳 CN | $1,0 Mrd. | D |
| 133 | ArriVent BioPharma Inc. US04272N1028 | 🇺🇸 US | $1,4 Mrd. | D |
| 134 | Jinyu Bio-technology Co. Ltd. CNE000000Y37 | 🇨🇳 CN | $2,2 Mrd. | D |
| 135 | Arrowhead Pharmaceuticals Inc. US04280A1007 | 🇺🇸 US | $12,5 Mrd. | D |
| 136 | Changchun High-Tech Industries (Group) Inc. CNE0000007J8 | 🇨🇳 CN | $5,1 Mrd. | D |
| 137 | PYC Therapeutics Limited AU000000PYC7 | 🇦🇺 AU | $887 Mio. | D |
| 138 | Revolution Medicines Inc. US76155X1000 | 🇺🇸 US | $45,1 Mrd. | D |
| 139 | Nuvalent Inc. US6707031075 | 🇺🇸 US | $9,1 Mrd. | D |
| 140 | Sol-Gel Technologies Ltd. IL0011417206 | 🇮🇱 IL | $277 Mio. | D |
| 141 | Niagen Bioscience Inc US1710774076 | 🇺🇸 US | $245 Mio. | D |
| 142 | Dyne Therapeutics Inc. US26818M1080 | 🇺🇸 US | $4,8 Mrd. | D |
| 143 | Mesoblast Limited AU000000MSB8 | 🇦🇺 AU | $2,3 Mrd. | D |
| 144 | Kodiak Sciences Inc. US50015M1099 | 🇺🇸 US | $2,6 Mrd. | D |
| 145 | Zai Lab Limited US98887Q1040 | 🇨🇳 CN | $2,9 Mrd. | D |
| 146 | Precigen Inc. US74017N1054 | 🇺🇸 US | $2,3 Mrd. | D |
| 147 | Abbisko Cayman Limited KYG0028A1085 | 🇨🇳 CN | $975 Mio. | D |
| 148 | Agenus Inc. US00847G8042 | 🇺🇸 US | $298 Mio. | D |
| 149 | Trevi Therapeutics Inc. US89532M1018 | 🇺🇸 US | $2,6 Mrd. | D |
| 150 | MannKind Corporation US56400P7069 | 🇺🇸 US | $1,2 Mrd. | D |
| 151 | Nuvation Bio Inc. US67080N1019 | 🇺🇸 US | $2,2 Mrd. | D |
| 152 | Syndax Pharmaceuticals Inc. US87164F1057 | 🇺🇸 US | $1,8 Mrd. | D |
| 153 | Ultragenyx Pharmaceutical Inc. US90400D1081 | 🇺🇸 US | $2,6 Mrd. | D |
| 154 | Pharvaris N.V. NL00150005Y4 | 🇳🇱 NL | $2,5 Mrd. | D |
| 155 | Vor Biopharma Inc. US9290332074 | 🇺🇸 US | $1,2 Mrd. | D |
| 156 | Apogee Therapeutics Inc. US03770N1019 | 🇺🇸 US | $8,3 Mrd. | D |
| 157 | Medy-Tox Inc. KR7086900008 | 🇰🇷 KR | $340 Mio. | D |
| 158 | COMPASS Pathways plc US20451W1018 | 🇬🇧 GB | $1,9 Mrd. | D |
| 159 | Onconic Therapeutics KR7476060009 | 🇰🇷 KR | $114 Mio. | D |
| 160 | Immunocore Holdings plc US45258D1054 | 🇬🇧 GB | $1,8 Mrd. | D |
| 161 | Kymera Therapeutics Inc. US5015751044 | 🇺🇸 US | $10,0 Mrd. | D |
| 162 | RemeGen Co. Ltd. CNE1000048G6 | 🇨🇳 CN | $5,7 Mrd. | D |
| 163 | Legend Biotech Corporation US52490G1022 | 🇺🇸 US | $3,8 Mrd. | D |
| 164 | Beam Therapeutics Inc. US07373V1052 | 🇺🇸 US | $2,8 Mrd. | D |
| 165 | Biohaven Ltd. VGG1110E1079 | 🇺🇸 US | $2,2 Mrd. | D |
| 166 | Zenas BioPharma Inc. US98937L1052 | 🇺🇸 US | $1,9 Mrd. | D |
| 167 | Akeso Inc. KYG0146B1032 | 🇨🇳 CN | $10,6 Mrd. | D |
| 168 | Spyre Therapeutics Inc. US00773J2024 | 🇺🇸 US | $9,0 Mrd. | D |
| 169 | CRISPR Therapeutics AG CH0334081137 | 🇨🇭 CH | $5,2 Mrd. | D |
| 170 | Agios Pharmaceuticals Inc. US00847X1046 | 🇺🇸 US | $2,0 Mrd. | D |
| 171 | Achieve Life Sciences Inc. US0044685008 | 🇺🇸 US | $770 Mio. | D |
| 172 | MedinCell S.A. FR0004065605 | 🇫🇷 FR | $1,0 Mrd. | D |
| 173 | Replimune Group Inc. US76029N1063 | 🇺🇸 US | $1,2 Mrd. | D |
| 174 | Viridian Therapeutics Inc. US92790C1045 | 🇺🇸 US | $2,5 Mrd. | D |
| 175 | Cogent Biosciences Inc. US19240Q2012 | 🇺🇸 US | $6,5 Mrd. | D |
| 176 | Oramed Pharmaceuticals Inc. US68403P2039 | 🇺🇸 US | $187 Mio. | D |
| 177 | Dianthus Therapeutics Inc. US2528281080 | 🇺🇸 US | $6,5 Mrd. | D |
| 178 | Kura Oncology Inc. US50127T1097 | 🇺🇸 US | $1,0 Mrd. | D |
| 179 | Definium Therapeutics Inc. CA24477V1058 | 🇺🇸 US | $5,7 Mrd. | D |
| 180 | Geron Corporation US3741631036 | 🇺🇸 US | $943 Mio. | D |
| 181 | uniQure N.V. NL0010696654 | 🇳🇱 NL | $3,3 Mrd. | D |
| 182 | Cullinan Therapeutics Inc. US2300311063 | 🇺🇸 US | $1,3 Mrd. | D |
| 183 | Pharming Group N.V. NL0010391025 | 🇳🇱 NL | $839 Mio. | D |
| 184 | Caliway Biopharmaceuticals Co. L TW0006919004 | 🇹🇼 TW | $5,0 Mrd. | D |
| 185 | Disc Medicine Inc. US2546041011 | 🇺🇸 US | $3,1 Mrd. | D |
| 186 | Oruka Therapeutics Inc. US6876041087 | 🇺🇸 US | $6,8 Mrd. | D |
| 187 | Financière de Tubize S.A. BE0003823409 | 🇧🇪 BE | $9,4 Mrd. | D |
| 188 | Arcus Biosciences Inc. US03969F1093 | 🇺🇸 US | $3,7 Mrd. | D |
| 189 | GNI Group Ltd. JP3386370005 | 🇯🇵 JP | $1,1 Mrd. | D |
| 190 | Stoke Therapeutics Inc. US86150R1077 | 🇺🇸 US | $2,0 Mrd. | D |
| 191 | Tango Therapeutics Inc. US87583X1090 | 🇺🇸 US | $4,2 Mrd. | D |
| 192 | Xenon Pharmaceuticals Inc. CA98420N1050 | 🇨🇦 CA | $6,0 Mrd. | D |
| 193 | SELLAS Life Sciences Group Inc. US81642T2096 | 🇺🇸 US | $2,4 Mrd. | D |
| 194 | Scholar Rock Holding Corporation US80706P1030 | 🇺🇸 US | $6,3 Mrd. | D |
| 195 | Erasca Inc. US29479A1088 | 🇺🇸 US | $6,4 Mrd. | D |
| 196 | Immunome Inc. US45257U1088 | 🇺🇸 US | $2,6 Mrd. | D |
| 197 | Ardelyx Inc. US0396971071 | 🇺🇸 US | $1,0 Mrd. | D |
| 198 | Relay Therapeutics Inc. US75943R1023 | 🇺🇸 US | $4,5 Mrd. | D |
| 199 | NRx Pharmaceuticals Inc. US6294442099 | 🇺🇸 US | $59 Mio. | D |
| 200 | Enliven Therapeutics Inc. US29337E1029 | 🇺🇸 US | $4,2 Mrd. | D |
| 201 | Taysha Gene Therapies Inc. US8776191061 | 🇺🇸 US | $1,9 Mrd. | D |
| 202 | Septerna Inc US81734D1046 | 🇺🇸 US | $2,0 Mrd. | D |
| 203 | Allogene Therapeutics Inc. US0197701065 | 🇺🇸 US | $718 Mio. | D |
| 204 | Gyre Therapeutics Inc. US4037831033 | 🇺🇸 US | $745 Mio. | D |
| 205 | Forte Biosciences Inc. US34962G2084 | 🇺🇸 US | $1,6 Mrd. | D |
| 206 | Foghorn Therapeutics Inc. US3441741077 | 🇺🇸 US | $368 Mio. | D |
| 207 | Monopar Therapeutics Inc. US61023L2079 | 🇺🇸 US | $780 Mio. | D |
| 208 | 4D Molecular Therapeutics Inc. US35104E1001 | 🇺🇸 US | $637 Mio. | D |
| 209 | Oxford Nanopore Technologies plc GB00BP6S8Z30 | 🇬🇧 GB | $1,6 Mrd. | D |
| 210 | Zymeworks Inc. US98985Y1082 | 🇺🇸 US | $1,8 Mrd. | D |
| 211 | Amylyx Pharmaceuticals Inc. US03237H1014 | 🇺🇸 US | $2,4 Mrd. | D |
| 212 | Orchestra BioMed Holdings Inc. US68572M1062 | 🇺🇸 US | $283 Mio. | D |
| 213 | Zentalis Pharmaceuticals Inc. US98943L1070 | 🇺🇸 US | $253 Mio. | D |
| 214 | BioAge Labs Inc. US09077V1008 | 🇺🇸 US | $392 Mio. | D |
| 215 | Vera Therapeutics Inc. US92337R1014 | 🇺🇸 US | $2,3 Mrd. | D |
| 216 | MBX Biosciences Inc. Common Stock US55287L1017 | 🇺🇸 US | $3,2 Mrd. | D |
| 217 | AN2 Therapeutics Inc. US0373261058 | 🇺🇸 US | $206 Mio. | D |
| 218 | Celldex Therapeutics Inc. US15117B2025 | 🇺🇸 US | $2,8 Mrd. | D |
| 219 | Ocular Therapeutix Inc. US67576A1007 | 🇺🇸 US | $2,3 Mrd. | D |
| 220 | Annexon Inc. US03589W1027 | 🇺🇸 US | $841 Mio. | D |
| 221 | Neuphoria Therapeutics Inc. US64136E1029 | 🇺🇸 US | $21 Mio. | D |
| 222 | OmniAb Inc. US68218J1034 | 🇺🇸 US | $554 Mio. | D |
| 223 | BioNTech SE US09075V1026 | 🇩🇪 DE | $23,0 Mrd. | D |
| 224 | Bicara Therapeutics Inc. Common Stock US0554771032 | 🇺🇸 US | $1,6 Mrd. | D |
| 225 | Celcuity Inc. US15102K1007 | 🇺🇸 US | $4,5 Mrd. | D |
| 226 | Intellia Therapeutics Inc. US45826J1051 | 🇺🇸 US | $1,7 Mrd. | D |
| 227 | Solid Biosciences Inc. US83422E2046 | 🇺🇸 US | $906 Mio. | D |
| 228 | Abivax S.A. FR0012333284 | 🇫🇷 FR | $10,7 Mrd. | D |
| 229 | CanSino Biologics Inc. CNE100003F01 | 🇨🇳 CN | $1,1 Mrd. | D |
| 230 | EyePoint Pharmaceuticals Inc. US30233G2093 | 🇺🇸 US | $1,2 Mrd. | D |
| 231 | AbCellera Biologics Inc. CA00288U1066 | 🇨🇦 CA | $3,4 Mrd. | D |
| 232 | Ascentage Pharma Group International KYG0519B1023 | 🇨🇳 CN | $1,7 Mrd. | D |
| 233 | OnKure Therapeutics Inc. US68277Q1058 | 🇺🇸 US | $166 Mio. | D |
| 234 | Denali Therapeutics Inc. US24823R1059 | 🇺🇸 US | $3,9 Mrd. | D |
| 235 | Vir Biotechnology Inc. US92764N1028 | 🇺🇸 US | $1,6 Mrd. | D |
| 236 | Rezolute Inc. US76200L3096 | 🇺🇸 US | $451 Mio. | D |
| 237 | Nektar Therapeutics US6402683063 | 🇺🇸 US | $2,1 Mrd. | D |
| 238 | Corvus Pharmaceuticals Inc. US2210151005 | 🇺🇸 US | $1,3 Mrd. | D |
| 239 | OliX PharmaceuticalsInc KR7226950004 | 🇰🇷 KR | $1,6 Mrd. | D |
| 240 | Structure Therapeutics Inc. US86366E1064 | 🇺🇸 US | $3,1 Mrd. | D |
| 241 | Savara Inc. US8051111016 | 🇺🇸 US | $1,1 Mrd. | D |
| 242 | ABL Bio Inc. KR7298380007 | 🇰🇷 KR | $3,2 Mrd. | D |
| 243 | GRAIL Inc. US3847471014 | 🇺🇸 US | $2,9 Mrd. | D |
| 244 | Abeona Therapeutics Inc. US00289Y2063 | 🇺🇸 US | $339 Mio. | D |
| 245 | Rapport Therapeutics Inc. Common Stock US75383L1026 | 🇺🇸 US | $2,3 Mrd. | D |
| 246 | Absci Corporation US00091E1091 | 🇺🇸 US | $1,6 Mrd. | D |
| 247 | Oxford Biomedica plc GB00BDFBVT43 | 🇬🇧 GB | $808 Mio. | D |
| 248 | Novavax Inc. US6700024010 | 🇺🇸 US | $1,3 Mrd. | D |
| 249 | Everest Medicines Limited KYG3224E1061 | 🇨🇳 CN | $1,3 Mrd. | D |
| 250 | Nkarta Inc. US65487U1088 | 🇺🇸 US | $174 Mio. | D |
| 251 | Phathom Pharmaceuticals Inc. US71722W1071 | 🇺🇸 US | $751 Mio. | D |
| 252 | GH Research PLC IE000GID8VI0 | 🇮🇪 IE | $2,0 Mrd. | D |
| 253 | Maravai LifeSciences Holdings Inc. US56600D1072 | 🇺🇸 US | $1,6 Mrd. | D |
| 254 | LB Pharmaceuticals Inc Common Stock US50180M1080 | 🇺🇸 US | $1,3 Mrd. | D |
| 255 | Xencor Inc. US98401F1057 | 🇺🇸 US | $1,7 Mrd. | D |
| 256 | CARsgen Therapeutics Holdings Limited KYG1996C1006 | 🇨🇳 CN | $1,0 Mrd. | D |
| 257 | Emergent BioSolutions Inc. US29089Q1058 | 🇺🇸 US | $237 Mio. | D |
| 258 | Lexicon Pharmaceuticals Inc. US5288723027 | 🇺🇸 US | $1,0 Mrd. | D |
| 259 | Duality Biotherapeutics Inc. KYG2929M1087 | 🇨🇳 CN | $2,1 Mrd. | D |
| 260 | Keymed Biosciences Inc. KYG5252B1023 | 🇨🇳 CN | $2,9 Mrd. | D |
| 261 | Damora Therapeutics Inc. KYG2646Y1044 | 🇺🇸 US | $1,9 Mrd. | D |
| 262 | Galectin Therapeutics Inc. US3632252025 | 🇺🇸 US | $227 Mio. | D |
| 263 | Design Therapeutics Inc. US25056L1035 | 🇺🇸 US | $926 Mio. | D |
| 264 | Arvinas Inc. US04335A1051 | 🇺🇸 US | $594 Mio. | D |
| 265 | Monte Rosa Therapeutics Inc. US61225M1027 | 🇺🇸 US | $1,3 Mrd. | D |
| 266 | Atai Beckley Inc. US04650F1012 | 🇺🇸 US | $2,7 Mrd. | D |
| 267 | Spruce Biosciences Inc. US85209E2081 | 🇺🇸 US | $145 Mio. | D |
| 268 | Sagimet Biosciences Inc. US7867001049 | 🇺🇸 US | $344 Mio. | D |
| 269 | Climb Bio Inc. US28658R1068 | 🇺🇸 US | $999 Mio. | D |
| 270 | Zura Bio Limited KYG9TY5A1016 | 🇺🇸 US | $526 Mio. | D |
| 271 | Relmada Therapeutics Inc. US75955J4022 | 🇺🇸 US | $500 Mio. | D |
| 272 | Mineralys Therapeutics Inc. US6031701013 | 🇺🇸 US | $2,3 Mrd. | D |
| 273 | Inhibrx Biosciences Inc. US45720N1037 | 🇺🇸 US | $1,3 Mrd. | D |
| 274 | Ocugen Inc. US67577C1053 | 🇺🇸 US | $466 Mio. | D |
| 275 | LigaChem Biosciences Inc. KR7141080002 | 🇰🇷 KR | $2,7 Mrd. | D |
| 276 | Sarepta Therapeutics Inc. US8036071004 | 🇺🇸 US | $1,9 Mrd. | D |
| 277 | GC Corp. KR7005250006 | 🇰🇷 KR | $324 Mio. | D |
| 278 | ORIC Pharmaceuticals Inc. US68622P1093 | 🇺🇸 US | $1,4 Mrd. | D |
| 279 | Tyra Biosciences Inc. US90240B1061 | 🇺🇸 US | $1,5 Mrd. | D |
| 280 | Alto Neuroscience Inc. US02157Q1094 | 🇺🇸 US | $1,2 Mrd. | D |
| 281 | Prelude Therapeutics Incorporated US74065P1012 | 🇺🇸 US | $321 Mio. | D |
| 282 | Tectonic Therapeutic Inc. US8789721086 | 🇺🇸 US | $659 Mio. | D |
| 283 | Palisade Bio Inc. US6963894026 | 🇺🇸 US | $373 Mio. | D |
| 284 | X4 Pharmaceuticals Inc. US98420X2027 | 🇺🇸 US | $398 Mio. | D |
| 285 | Ovid Therapeutics Inc. US6904691010 | 🇺🇸 US | $539 Mio. | D |
| 286 | Candel Therapeutics Inc. US1374041093 | 🇺🇸 US | $891 Mio. | D |
| 287 | Sana Biotechnology Inc. US7995661045 | 🇺🇸 US | $1,0 Mrd. | D |
| 288 | C4 Therapeutics Inc. US12529R1077 | 🇺🇸 US | $472 Mio. | D |
| 289 | Larimar Therapeutics Inc. US5171251003 | 🇺🇸 US | $449 Mio. | D |
| 290 | Valneva SE FR0004056851 | 🇫🇷 FR | $659 Mio. | D |
| 291 | Kyverna Therapeutics Inc. US5019761049 | 🇺🇸 US | $544 Mio. | D |
| 292 | Aclaris Therapeutics Inc. US00461U1051 | 🇺🇸 US | $827 Mio. | D |
| 293 | Immix Biopharma Inc. US45258H1068 | 🇺🇸 US | $617 Mio. | D |
| 294 | SK bioscience Co.Ltd. KR7302440003 | 🇰🇷 KR | $2,0 Mrd. | D |
| 295 | SAB Biotherapeutics Inc. US78397T2024 | 🇺🇸 US | $343 Mio. | D |
| 296 | NewAmsterdam Pharma Company N.V. NL00150012L7 | 🇳🇱 NL | $3,1 Mrd. | D |
| 297 | MacroGenics Inc. US5560991094 | 🇺🇸 US | $258 Mio. | D |
| 298 | Jade Biosciences Inc. US0080642061 | 🇺🇸 US | $1,4 Mrd. | D |
| 299 | Ocumension Therapeutics KYG674111011 | 🇨🇳 CN | $548 Mio. | D |
| 300 | Cue Biopharma Inc. US22978P2056 | 🇺🇸 US | $80 Mio. | D |
| 301 | OPKO Health Inc. US68375N1037 | 🇺🇸 US | $1,0 Mrd. | D |
| 302 | D&D Pharmatech KR7347850000 | 🇰🇷 KR | $1,9 Mrd. | D |
| 303 | Shattuck Labs Inc. US82024L1035 | 🇺🇸 US | $671 Mio. | D |
| 304 | Precision BioSciences Inc. US74019P2074 | 🇺🇸 US | $95 Mio. | D |
| 305 | Nxera Pharma Co. Ltd. JP3431300007 | 🇯🇵 JP | $646 Mio. | D |
| 306 | Adimmune Corporation TW0004142005 | 🇹🇼 TW | $228 Mio. | D |
| 307 | Viking Therapeutics Inc. US92686J1060 | 🇺🇸 US | $3,9 Mrd. | D |
| 308 | Chongqing Zhifei Biological Products Co. Ltd. CNE100000V20 | 🇨🇳 CN | $4,6 Mrd. | D |
| 309 | Vanda Pharmaceuticals Inc. US9216591084 | 🇺🇸 US | $314 Mio. | D |
| 310 | Neurogene Inc. US64135M1053 | 🇺🇸 US | $580 Mio. | D |
| 311 | Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. CNE100004090 | 🇨🇳 CN | $5,6 Mrd. | D |
| 312 | Artiva Biotherapeutics Inc. US04317A1079 | 🇺🇸 US | $574 Mio. | D |
| 313 | Rocket Pharmaceuticals Inc. US77313F1066 | 🇺🇸 US | $371 Mio. | D |
| 314 | Fate Therapeutics Inc. US31189P1021 | 🇺🇸 US | $300 Mio. | D |
| 315 | Recursion Pharmaceuticals Inc. US75629V1044 | 🇺🇸 US | $1,6 Mrd. | D |
| 316 | Atea Pharmaceuticals Inc. US04683R1068 | 🇺🇸 US | $418 Mio. | D |
| 317 | Immatics N.V. NL0015285941 | 🇩🇪 DE | $1,2 Mrd. | D |
| 318 | REGENXBIO Inc. US75901B1070 | 🇺🇸 US | $586 Mio. | D |
| 319 | Alphamab Oncology KYG0330A1013 | 🇨🇳 CN | $1,0 Mrd. | D |
| 320 | Oneness Biotech Co. Ltd. TW0004743000 | 🇹🇼 TW | $706 Mio. | D |
| 321 | Nuvectis Pharma Inc. US67080T1088 | 🇺🇸 US | $506 Mio. | D |
| 322 | Unicycive Therapeutics Inc. US90466Y2028 | 🇺🇸 US | $147 Mio. | D |
| 323 | Tonix Pharmaceuticals Holding Corp. US8902608392 | 🇺🇸 US | $203 Mio. | D |
| 324 | Karyopharm Therapeutics Inc. US48576U2050 | 🇺🇸 US | $41 Mio. | D |
| 325 | Whitehawk Therapeutics Inc US00032Q1040 | 🇺🇸 US | $254 Mio. | D |
| 326 | Aura Biosciences Inc. US05153U1079 | 🇺🇸 US | $794 Mio. | D |
| 327 | ARS Pharmaceuticals Inc. US82835W1080 | 🇺🇸 US | $561 Mio. | D |
| 328 | Contineum Therapeutics Inc. US21217B1008 | 🇺🇸 US | $534 Mio. | D |
| 329 | Peptron Inc. KR7087010005 | 🇰🇷 KR | $3,1 Mrd. | D |
| 330 | Chabiotech Co.Ltd. KR7085660009 | 🇰🇷 KR | $601 Mio. | D |
| 331 | Assembly Biosciences Inc. US0453962070 | 🇺🇸 US | $595 Mio. | D |
| 332 | HLB Co. Ltd. KR7028300002 | 🇰🇷 KR | $4,0 Mrd. | D |
| 333 | Enanta Pharmaceuticals Inc. US29251M1062 | 🇺🇸 US | $383 Mio. | D |
| 334 | Crescent Biopharma Inc. KYG2545C1042 | 🇺🇸 US | $649 Mio. | D |
| 335 | Arcturus Therapeutics Holdings Inc. US03969T1097 | 🇺🇸 US | $231 Mio. | D |
| 336 | Summit Therapeutics Inc. US86627T1088 | 🇺🇸 US | $10,7 Mrd. | D |
| 337 | SanBio Company Limited JP3336750009 | 🇯🇵 JP | $500 Mio. | D |
| 338 | Inhibikase Therapeutics Inc. US45719W2052 | 🇺🇸 US | $316 Mio. | D |
| 339 | Eledon Pharmaceuticals Inc. US28617K1016 | 🇺🇸 US | $273 Mio. | D |
| 340 | Quantum BioPharma Ltd. CA74764Y2050 | 🇨🇦 CA | $24 Mio. | D |
| 341 | Bright Minds Biosciences Inc. CA10919W4056 | 🇺🇸 US | $758 Mio. | D |
| 342 | Entrada Therapeutics Inc. US29384C1080 | 🇺🇸 US | $290 Mio. | D |
| 343 | LENZ Therapeutics Inc. US52635N1037 | 🇺🇸 US | $150 Mio. | D |
| 344 | Heron Therapeutics Inc. US4277461020 | 🇺🇸 US | $61 Mio. | D |
| 345 | CStone Pharmaceuticals KYG2588M1006 | 🇨🇳 CN | $1,1 Mrd. | D |
| 346 | Avalo Therapeutics Inc. US05338F3064 | 🇺🇸 US | $1,0 Mrd. | D |
| 347 | Voronoi Inc. KR7310210000 | 🇰🇷 KR | $2,2 Mrd. | D |
| 348 | Verastem Inc. US92337C2035 | 🇺🇸 US | $578 Mio. | D |
| 349 | ADC Therapeutics S.A. CH0499880968 | 🇨🇭 CH | $140 Mio. | D |
| 350 | Orum Therapeutics Inc. KR7475830006 | 🇰🇷 KR | $976 Mio. | D |
| 351 | BINEX Co. Ltd. KR7053030003 | 🇰🇷 KR | $156 Mio. | D |
| 352 | Alector Inc. US0144421072 | 🇺🇸 US | $228 Mio. | D |
| 353 | Maze Therapeutics Inc. US5787841007 | 🇺🇸 US | $1,5 Mrd. | D |
| 354 | Janux Therapeutics Inc. US47103J1051 | 🇺🇸 US | $992 Mio. | D |
| 355 | MapLight Therapeutics Inc. US56565P1030 | 🇺🇸 US | $477 Mio. | D |
| 356 | CytomX Therapeutics Inc. US23284F1057 | 🇺🇸 US | $731 Mio. | D |
| 357 | CAMP4 Therapeutics Corporation US13463J1016 | 🇺🇸 US | $106 Mio. | D |
| 358 | CervoMed Inc. US15713L1098 | 🇺🇸 US | $28 Mio. | D |
| 359 | DiaMedica Therapeutics Inc. CA25253X2077 | 🇺🇸 US | $360 Mio. | D |
| 360 | Editas Medicine Inc. US28106W1036 | 🇺🇸 US | $433 Mio. | D |
| 361 | Inventiva S.A. US46124U1079 | 🇫🇷 FR | $283 Mio. | D |
| 362 | MoonLake Immunotherapeutics KY61559X1045 | 🇨🇭 CH | $1,4 Mrd. | D |
| 363 | Fulcrum Therapeutics Inc. US3596161097 | 🇺🇸 US | $285 Mio. | D |
| 364 | Cabaletta Bio Inc. US12674W1099 | 🇺🇸 US | $471 Mio. | D |
| 365 | ALX Oncology Holdings Inc. US00166B1052 | 🇺🇸 US | $265 Mio. | D |
| 366 | Aligos Therapeutics Inc. US01626L2043 | 🇺🇸 US | $43 Mio. | D |
| 367 | Cartesian Therapeutics Inc. US8162123025 | 🇺🇸 US | $270 Mio. | D |
| 368 | Prime Medicine Inc. US74168J1016 | 🇺🇸 US | $573 Mio. | D |
| 369 | Century Therapeutics Inc. US15673T1007 | 🇺🇸 US | $169 Mio. | D |
| 370 | Akebia Therapeutics Inc. US00972D1054 | 🇺🇸 US | $231 Mio. | D |
| 371 | MediWound Ltd. IL0011316309 | 🇮🇱 IL | $172 Mio. | D |
| 372 | Opus Genetics Inc. US67577R1023 | 🇺🇸 US | $301 Mio. | D |
| 373 | Surrozen Inc. US86889P2083 | 🇺🇸 US | $179 Mio. | D |
| 374 | Acumen Pharmaceuticals Inc. US00509G2093 | 🇺🇸 US | $192 Mio. | D |
| 375 | Altimmune Inc. US02155H2004 | 🇺🇸 US | $583 Mio. | D |
| 376 | PeptiDream Inc. JP3836750004 | 🇯🇵 JP | $833 Mio. | D |
| 377 | Benitec Biopharma Inc. US08205P2092 | 🇺🇸 US | $449 Mio. | D |
| 378 | Sutro Biopharma Inc. US8693672011 | 🇺🇸 US | $198 Mio. | D |
| 379 | Olema Pharmaceuticals Inc. US68062P1066 | 🇺🇸 US | $941 Mio. | D |
| 380 | Quantum-Si incorporated US74765K1051 | 🇺🇸 US | $147 Mio. | D |
| 381 | Prothena Corporation plc IE00B91XRN20 | 🇮🇪 IE | $465 Mio. | D |
| 382 | Milestone Pharmaceuticals Inc. CA59935V1076 | 🇨🇦 CA | $137 Mio. | D |
| 383 | Minerva Neurosciences Inc. US6033802058 | 🇺🇸 US | $206 Mio. | D |
| 384 | Neumora Therapeutics Inc. Common Stock US6409791000 | 🇺🇸 US | $282 Mio. | D |
| 385 | Daan Gene Co. Ltd. CNE000001KP1 | 🇨🇳 CN | $1,2 Mrd. | D |
| 386 | Hebei Changshan Biochemical Pharmaceutical Co. Ltd. CNE1000016C2 | 🇨🇳 CN | $3,7 Mrd. | D |
| 387 | Codexis Inc. US1920051067 | 🇺🇸 US | $171 Mio. | D |
| 388 | Ascletis Pharma Inc. KYG0520K1094 | 🇨🇳 CN | $1,4 Mrd. | D |
| 389 | Ginkgo Bioworks Holdings Inc. US37611X2099 | 🇺🇸 US | $444 Mio. | D |
| 390 | Immuneering Corporation US45254E1073 | 🇺🇸 US | $189 Mio. | D |
| 391 | Greenwich LifeSciences Inc. US3968791083 | 🇺🇸 US | $247 Mio. | D |
| 392 | Compass Therapeutics Inc. US20454B1044 | 🇺🇸 US | $416 Mio. | D |
| 393 | Coeptis Therapeutics Holdings Inc. US98878K1088 | 🇺🇸 US | $39 Mio. | D |
| 394 | Sionna Therapeutics Inc. US8294011080 | 🇺🇸 US | $292 Mio. | D |
| 395 | Coherus Oncology Inc. US19249H1032 | 🇺🇸 US | $178 Mio. | D |
| 396 | Oculis Holding AG CH1242303498 | 🇨🇭 CH | $751 Mio. | D |
| 397 | Wave Life Sciences Ltd. SG9999014716 | 🇸🇬 SG | $1,1 Mrd. | D |
| 398 | Korro Bio Inc. US5009461089 | 🇺🇸 US | $131 Mio. | D |
| 399 | Lumosa Therapeutics Co. Ltd. TW0006535008 | 🇹🇼 TW | $452 Mio. | D |
| 400 | ProKidney Corp. US74291D1046 | 🇺🇸 US | $471 Mio. | D |
| 401 | Keros Therapeutics Inc. US4923271013 | 🇺🇸 US | $335 Mio. | D |
| 402 | Capricor Therapeutics Inc. US14070B3096 | 🇺🇸 US | $428 Mio. | D |
| 403 | Tharimmune Inc. US4327053090 | 🇺🇸 US | $140 Mio. | D |
| 404 | Canton Strategic Holdings Inc US4327053090 | 🇺🇸 US | $156 Mio. | D |
| 405 | Nautilus Biotechnolgy Inc. US63909J1088 | 🇺🇸 US | $112 Mio. | D |
| 406 | GI Innovation Inc. KR7358570000 | 🇰🇷 KR | $395 Mio. | D |
| 407 | Upstream Bio Inc. US91678A1079 | 🇺🇸 US | $385 Mio. | D |
| 408 | Caribou Biosciences Inc. US1420381089 | 🇺🇸 US | $157 Mio. | D |
| 409 | Tenax Therapeutics Inc. US88032L6056 | 🇺🇸 US | $48 Mio. | D |
| 410 | Lexeo Therapeutics Inc. Common Stock US52886X1072 | 🇺🇸 US | $391 Mio. | D |
| 411 | Black Diamond Therapeutics Inc. US09203E1055 | 🇺🇸 US | $117 Mio. | D |
| 412 | Anavex Life Sciences Corp. US0327973006 | 🇺🇸 US | $297 Mio. | D |
| 413 | Corbus Pharmaceuticals Holdings Inc. US21833P3010 | 🇺🇸 US | $187 Mio. | D |
| 414 | Voyager Therapeutics Inc. US92915B1061 | 🇺🇸 US | $198 Mio. | D |
| 415 | Protara Therapeutics Inc. US74365U1079 | 🇺🇸 US | $223 Mio. | D |
| 416 | Hyundai Bioscience Co. Ltd. KR7048410005 | 🇰🇷 KR | $517 Mio. | D |
| 417 | Lyell Immunopharma Inc. US55083R2031 | 🇺🇸 US | $332 Mio. | D |
| 418 | Lineage Cell Therapeutics Inc. US53566P1093 | 🇺🇸 US | $264 Mio. | D |
| 1 | Vertex Pharmaceuticals Incorporated US92532F1003 | 🇺🇸 US | $128,4 Mrd. | A+ |
| 2 | Regeneron Pharmaceuticals Inc. US75886F1075 | 🇺🇸 US | $83,0 Mrd. | A+ |
| 3 | argenx SE NL0010832176 | 🇳🇱 NL | $61,6 Mrd. | A+ |
| 4 | Samsung Biologics Co.Ltd. KR7207940008 | 🇰🇷 KR | $49,8 Mrd. | B+ |
| 5 | Lonza Group AG CH0013841017 | 🇨🇭 CH | $48,8 Mrd. | B |
| 6 | UCB S.A. BE0003739530 | 🇧🇪 BE | $48,1 Mrd. | A |
| 7 | CSL Limited AU000000CSL8 | 🇦🇺 AU | $46,4 Mrd. | B |
| 8 | Revolution Medicines Inc. US76155X1000 | 🇺🇸 US | $45,1 Mrd. | D |
| 9 | BeOne Medicines Ltd. Class A CNE100005XT6 | 🇨🇭 CH | $45,0 Mrd. | A |
| 10 | BeOne Medicines AG CH1391448177 | 🇨🇭 CH | $36,3 Mrd. | A |
| 11 | Celltrion Inc. KR7068270008 | 🇰🇷 KR | $31,9 Mrd. | B+ |
| 12 | Alnylam Pharmaceuticals Inc. US02043Q1076 | 🇺🇸 US | $30,1 Mrd. | B |
| 13 | Insmed Incorporated US4576693075 | 🇺🇸 US | $27,8 Mrd. | D |
| 14 | Roivant Sciences Ltd. BMG762791017 | 🇬🇧 GB | $26,2 Mrd. | C |
| 15 | Moderna Inc. US60770K1079 | 🇺🇸 US | $25,6 Mrd. | C |
| 16 | Incyte Corporation US45337C1027 | 🇺🇸 US | $25,0 Mrd. | A+ |
| 17 | WuXi Biologics (Cayman) Inc. KYG970081173 | 🇨🇳 CN | $24,4 Mrd. | A+ |
| 18 | BioNTech SE US09075V1026 | 🇩🇪 DE | $23,0 Mrd. | D |
| 19 | United Therapeutics Corporation US91307C1027 | 🇺🇸 US | $21,2 Mrd. | A+ |
| 20 | Innovent Biologics Inc. KYG4818G1010 | 🇨🇳 CN | $21,2 Mrd. | B |
| 21 | Genmab A/S DK0010272202 | 🇩🇰 DK | $19,3 Mrd. | B+ |
| 22 | BridgeBio Pharma Inc. US10806X1028 | 🇺🇸 US | $15,6 Mrd. | B |
| 23 | Jazz Pharmaceuticals plc IE00B4Q5ZN47 | 🇮🇪 IE | $15,6 Mrd. | A |
| 24 | Neurocrine Biosciences Inc. US64125C1099 | 🇺🇸 US | $15,5 Mrd. | A+ |
| 25 | Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. CNE1000062J1 | 🇨🇳 CN | $15,5 Mrd. | C |
| 26 | Ascendis Pharma A/S DK0060615755 | 🇩🇰 DK | $15,4 Mrd. | A+ |
| 27 | Alteogen Inc. KR7196170005 | 🇰🇷 KR | $15,0 Mrd. | B |
| 28 | BioMarin Pharmaceutical Inc. US09061G1013 | 🇺🇸 US | $12,9 Mrd. | B+ |
| 29 | Exelixis Inc. US30161Q1040 | 🇺🇸 US | $12,9 Mrd. | A+ |
| 30 | Arrowhead Pharmaceuticals Inc. US04280A1007 | 🇺🇸 US | $12,5 Mrd. | D |
| 31 | Madrigal Pharmaceuticals Inc. US5588681057 | 🇺🇸 US | $12,1 Mrd. | C |
| 32 | Halozyme Therapeutics Inc. US40637H1095 | 🇺🇸 US | $11,7 Mrd. | A+ |
| 33 | Haisco Pharmaceutical Group Co. Ltd. CNE100001BC7 | 🇨🇳 CN | $11,7 Mrd. | C |
| 34 | Bio-Techne Corporation US09073M1045 | 🇺🇸 US | $11,3 Mrd. | A |
| 35 | Axsome Therapeutics Inc. US05464T1043 | 🇺🇸 US | $11,1 Mrd. | B |
| 36 | Sichuan Kelun Pharmaceutical Co. Ltd. Class A CNE100000PW7 | 🇨🇳 CN | $11,0 Mrd. | B+ |
| 37 | RemeGen Co. Ltd. Class A CNE100005B03 | 🇨🇳 CN | $11,0 Mrd. | C |
| 38 | Pharmaron Beijing Co. Ltd. CNE100003JW4 | 🇨🇳 CN | $11,0 Mrd. | A+ |
| 39 | Abivax S.A. FR0012333284 | 🇫🇷 FR | $10,7 Mrd. | D |
| 40 | Summit Therapeutics Inc. US86627T1088 | 🇺🇸 US | $10,7 Mrd. | D |
| 41 | Akeso Inc. KYG0146B1032 | 🇨🇳 CN | $10,6 Mrd. | D |
| 42 | Praxis Precision Medicines Inc. US74006W2070 | 🇺🇸 US | $10,5 Mrd. | C |
| 43 | Protagonist Therapeutics Inc. US74366E1029 | 🇺🇸 US | $10,2 Mrd. | C |
| 44 | Kymera Therapeutics Inc. US5015751044 | 🇺🇸 US | $10,0 Mrd. | D |
| 45 | Krystal Biotech Inc. US5011471027 | 🇺🇸 US | $9,9 Mrd. | A |
| 46 | Ionis Pharmaceuticals Inc. US4622221004 | 🇺🇸 US | $9,7 Mrd. | D |
| 47 | Financière de Tubize S.A. BE0003823409 | 🇧🇪 BE | $9,4 Mrd. | D |
| 48 | Cytokinetics Incorporated US23282W6057 | 🇺🇸 US | $9,2 Mrd. | D |
| 49 | Nuvalent Inc. US6707031075 | 🇺🇸 US | $9,1 Mrd. | D |
| 50 | Immunovant Inc. US45258J1025 | 🇺🇸 US | $9,0 Mrd. | D |
| 51 | Spyre Therapeutics Inc. US00773J2024 | 🇺🇸 US | $9,0 Mrd. | D |
| 52 | Crinetics Pharmaceuticals Inc. US22663K1079 | 🇺🇸 US | $9,0 Mrd. | C |
| 53 | Asymchem Laboratories (Tianjin) Co. Ltd. CNE100002BZ6 | 🇨🇳 CN | $8,8 Mrd. | B+ |
| 54 | Vaxcyte Inc. US92243G1085 | 🇺🇸 US | $8,7 Mrd. | C |
| 55 | Alkermes plc IE00B56GVS15 | 🇮🇪 IE | $8,4 Mrd. | A |
| 56 | Apogee Therapeutics Inc. US03770N1019 | 🇺🇸 US | $8,3 Mrd. | D |
| 57 | ImmunityBio Inc. US45256X1037 | 🇺🇸 US | $8,3 Mrd. | C |
| 58 | Shanghai Allist Pharmaceuticals Co. Ltd. CNE100005XJ7 | 🇨🇳 CN | $8,0 Mrd. | A+ |
| 59 | Rhythm Pharmaceuticals Inc. US76243J1051 | 🇺🇸 US | $7,9 Mrd. | C |
| 60 | ALK-Abelló A/S DK0061802139 | 🇩🇰 DK | $7,5 Mrd. | A+ |
| 61 | TG Therapeutics Inc. US88322Q1085 | 🇺🇸 US | $7,5 Mrd. | A+ |
| 62 | Genscript Biotech Corporation KYG3825B1059 | 🇭🇰 HK | $7,3 Mrd. | C |
| 63 | Bachem Holding AG CH1176493729 | 🇨🇭 CH | $6,9 Mrd. | A |
| 64 | CG Oncology Inc. US1569441009 | 🇺🇸 US | $6,8 Mrd. | C |
| 65 | Oruka Therapeutics Inc. US6876041087 | 🇺🇸 US | $6,8 Mrd. | D |
| 66 | Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd CNE1000062X2 | 🇨🇳 CN | $6,5 Mrd. | A+ |
| 67 | Dianthus Therapeutics Inc. US2528281080 | 🇺🇸 US | $6,5 Mrd. | D |
| 68 | Cogent Biosciences Inc. US19240Q2012 | 🇺🇸 US | $6,5 Mrd. | D |
| 69 | Erasca Inc. US29479A1088 | 🇺🇸 US | $6,4 Mrd. | D |
| 70 | Hangzhou Tigermed Consulting Co. Ltd CNE1000040M1 | 🇨🇳 CN | $6,4 Mrd. | C |
| 71 | Scholar Rock Holding Corporation US80706P1030 | 🇺🇸 US | $6,3 Mrd. | D |
| 72 | Caris Life Sciences Inc. US1421521071 | 🇺🇸 US | $6,1 Mrd. | C |
| 73 | Mirum Pharmaceuticals Inc. US6047491013 | 🇺🇸 US | $6,1 Mrd. | C |
| 74 | PTC Therapeutics Inc. US69366J2006 | 🇺🇸 US | $6,1 Mrd. | C |
| 75 | Xenon Pharmaceuticals Inc. CA98420N1050 | 🇨🇦 CA | $6,0 Mrd. | D |
| 76 | Shanghai Junshi Biosciences Co. Ltd. CNE1000041Z1 | 🇨🇳 CN | $5,9 Mrd. | D |
| 77 | Biocon Limited INE376G01013 | 🇮🇳 IN | $5,9 Mrd. | B |
| 78 | Ligand Pharmaceuticals Incorporated US53220K5048 | 🇺🇸 US | $5,8 Mrd. | A+ |
| 79 | Travere Therapeutics Inc. US89422G1076 | 🇺🇸 US | $5,8 Mrd. | B+ |
| 80 | RemeGen Co. Ltd. CNE1000048G6 | 🇨🇳 CN | $5,7 Mrd. | D |
| 81 | Definium Therapeutics Inc. CA24477V1058 | 🇺🇸 US | $5,7 Mrd. | D |
| 82 | 3SBio Inc. KYG8875G1029 | 🇨🇳 CN | $5,6 Mrd. | B |
| 83 | Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. CNE100004090 | 🇨🇳 CN | $5,6 Mrd. | D |
| 84 | Anthem Biosciences Ltd. INE0CZ201020 | 🇮🇳 IN | $5,3 Mrd. | A+ |
| 85 | CRISPR Therapeutics AG CH0334081137 | 🇨🇭 CH | $5,2 Mrd. | D |
| 86 | Changchun High-Tech Industries (Group) Inc. CNE0000007J8 | 🇨🇳 CN | $5,1 Mrd. | D |
| 87 | Caliway Biopharmaceuticals Co. L TW0006919004 | 🇹🇼 TW | $5,0 Mrd. | D |
| 88 | ACADIA Pharmaceuticals Inc. US0042251084 | 🇺🇸 US | $5,0 Mrd. | A+ |
| 89 | Shanghai RAAS Blood Products Co. Ltd. CNE100000C31 | 🇨🇳 CN | $4,8 Mrd. | C |
| 90 | Dyne Therapeutics Inc. US26818M1080 | 🇺🇸 US | $4,8 Mrd. | D |
| 91 | Suzhou Zelgen Biopharmaceuticals Co. Ltd. CNE100003RP1 | 🇨🇳 CN | $4,8 Mrd. | B |
| 92 | Edgewise Therapeutics Inc. US28036F1057 | 🇺🇸 US | $4,8 Mrd. | D |
| 93 | SK Biopharmaceuticals Co. Ltd. KR7326030004 | 🇰🇷 KR | $4,8 Mrd. | C |
| 94 | Chongqing Zhifei Biological Products Co. Ltd. CNE100000V20 | 🇨🇳 CN | $4,6 Mrd. | D |
| 95 | Relay Therapeutics Inc. US75943R1023 | 🇺🇸 US | $4,5 Mrd. | D |
| 96 | Celcuity Inc. US15102K1007 | 🇺🇸 US | $4,5 Mrd. | D |
| 97 | XtalPi Holdings Ltd KYG7S12M1051 | 🇨🇳 CN | $4,3 Mrd. | D |
| 98 | Enliven Therapeutics Inc. US29337E1029 | 🇺🇸 US | $4,2 Mrd. | D |
| 99 | Tango Therapeutics Inc. US87583X1090 | 🇺🇸 US | $4,2 Mrd. | D |
| 100 | Simcere Pharmaceutical Group Limited HK0000658531 | 🇨🇳 CN | $4,0 Mrd. | A |
| 101 | HLB Co. Ltd. KR7028300002 | 🇰🇷 KR | $4,0 Mrd. | D |
| 102 | Telix Pharmaceuticals Limited AU000000TLX2 | 🇦🇺 AU | $4,0 Mrd. | C |
| 103 | Adaptive Biotechnologies Corporation US00650F1093 | 🇺🇸 US | $4,0 Mrd. | C |
| 104 | Denali Therapeutics Inc. US24823R1059 | 🇺🇸 US | $3,9 Mrd. | D |
| 105 | Viking Therapeutics Inc. US92686J1060 | 🇺🇸 US | $3,9 Mrd. | D |
| 106 | Catalyst Pharmaceuticals Inc. US14888U1016 | 🇺🇸 US | $3,9 Mrd. | A+ |
| 107 | Camurus AB SE0007692850 | 🇸🇪 SE | $3,8 Mrd. | B+ |
| 108 | Legend Biotech Corporation US52490G1022 | 🇺🇸 US | $3,8 Mrd. | D |
| 109 | Hebei Changshan Biochemical Pharmaceutical Co. Ltd. CNE1000016C2 | 🇨🇳 CN | $3,7 Mrd. | D |
| 110 | Arcus Biosciences Inc. US03969F1093 | 🇺🇸 US | $3,7 Mrd. | D |
| 111 | Beijing Tiantan Biological Products Co. Ltd. CNE000000WF9 | 🇨🇳 CN | $3,6 Mrd. | C |
| 112 | Hualan Biological Engineering Inc. CNE000001JN8 | 🇨🇳 CN | $3,6 Mrd. | C |
| 113 | Xiamen Amoytop Biotech Co. Ltd. CNE100003RT3 | 🇨🇳 CN | $3,5 Mrd. | B |
| 114 | IDEAYA Biosciences Inc. US45166A1025 | 🇺🇸 US | $3,5 Mrd. | D |
| 115 | AbCellera Biologics Inc. CA00288U1066 | 🇨🇦 CA | $3,4 Mrd. | D |
| 116 | Zealand Pharma A/S DK0060257814 | 🇩🇰 DK | $3,4 Mrd. | C |
| 117 | uniQure N.V. NL0010696654 | 🇳🇱 NL | $3,3 Mrd. | D |
| 118 | Biocytogen Pharmaceuticals (Beijing) Co. Ltd. CNE100005D27 | 🇨🇳 CN | $3,3 Mrd. | B |
| 119 | MBX Biosciences Inc. Common Stock US55287L1017 | 🇺🇸 US | $3,2 Mrd. | D |
| 120 | ABL Bio Inc. KR7298380007 | 🇰🇷 KR | $3,2 Mrd. | D |
| 121 | Arcutis Biotherapeutics Inc. US03969K1088 | 🇺🇸 US | $3,2 Mrd. | B+ |
| 122 | Iovance Biotherapeutics Inc. US4622601007 | 🇺🇸 US | $3,2 Mrd. | C |
| 123 | Alumis Inc. US0223071020 | 🇺🇸 US | $3,1 Mrd. | D |
| 124 | NewAmsterdam Pharma Company N.V. NL00150012L7 | 🇳🇱 NL | $3,1 Mrd. | D |
| 125 | Structure Therapeutics Inc. US86366E1064 | 🇺🇸 US | $3,1 Mrd. | D |
| 126 | Peptron Inc. KR7087010005 | 🇰🇷 KR | $3,1 Mrd. | D |
| 127 | Disc Medicine Inc. US2546041011 | 🇺🇸 US | $3,1 Mrd. | D |
| 128 | BioArctic AB SE0010323311 | 🇸🇪 SE | $3,0 Mrd. | B |
| 129 | DaShenLin Pharmaceutical Group Co. Ltd. CNE100002RG2 | 🇨🇳 CN | $3,0 Mrd. | A |
| 130 | Tarsus Pharmaceuticals Inc. US87650L1035 | 🇺🇸 US | $3,0 Mrd. | C |
| 131 | Zai Lab Limited US98887Q1040 | 🇨🇳 CN | $2,9 Mrd. | D |
| 132 | GRAIL Inc. US3847471014 | 🇺🇸 US | $2,9 Mrd. | D |
| 133 | Keymed Biosciences Inc. KYG5252B1023 | 🇨🇳 CN | $2,9 Mrd. | D |
| 134 | Nurix Therapeutics Inc. US67080M1036 | 🇺🇸 US | $2,8 Mrd. | D |
| 135 | Celldex Therapeutics Inc. US15117B2025 | 🇺🇸 US | $2,8 Mrd. | D |
| 136 | Beam Therapeutics Inc. US07373V1052 | 🇺🇸 US | $2,8 Mrd. | D |
| 137 | InnoCare Pharma Limited KYG4783B1032 | 🇨🇳 CN | $2,8 Mrd. | B |
| 138 | LigaChem Biosciences Inc. KR7141080002 | 🇰🇷 KR | $2,7 Mrd. | D |
| 139 | Atai Beckley Inc. US04650F1012 | 🇺🇸 US | $2,7 Mrd. | D |
| 140 | Trevi Therapeutics Inc. US89532M1018 | 🇺🇸 US | $2,6 Mrd. | D |
| 141 | Immunome Inc. US45257U1088 | 🇺🇸 US | $2,6 Mrd. | D |
| 142 | Ultragenyx Pharmaceutical Inc. US90400D1081 | 🇺🇸 US | $2,6 Mrd. | D |
| 143 | Kodiak Sciences Inc. US50015M1099 | 🇺🇸 US | $2,6 Mrd. | D |
| 144 | BioCryst Pharmaceuticals Inc. US09058V1035 | 🇺🇸 US | $2,5 Mrd. | D |
| 145 | Viridian Therapeutics Inc. US92790C1045 | 🇺🇸 US | $2,5 Mrd. | D |
| 146 | Pharvaris N.V. NL00150005Y4 | 🇳🇱 NL | $2,5 Mrd. | D |
| 147 | Amylyx Pharmaceuticals Inc. US03237H1014 | 🇺🇸 US | $2,4 Mrd. | D |
| 148 | SELLAS Life Sciences Group Inc. US81642T2096 | 🇺🇸 US | $2,4 Mrd. | D |
| 149 | UroGen Pharma Ltd. IL0011407140 | 🇺🇸 US | $2,3 Mrd. | B |
| 150 | Precigen Inc. US74017N1054 | 🇺🇸 US | $2,3 Mrd. | D |
| 151 | Ocular Therapeutix Inc. US67576A1007 | 🇺🇸 US | $2,3 Mrd. | D |
| 152 | Rapport Therapeutics Inc. Common Stock US75383L1026 | 🇺🇸 US | $2,3 Mrd. | D |
| 153 | Mineralys Therapeutics Inc. US6031701013 | 🇺🇸 US | $2,3 Mrd. | D |
| 154 | Vera Therapeutics Inc. US92337R1014 | 🇺🇸 US | $2,3 Mrd. | D |
| 155 | Mesoblast Limited AU000000MSB8 | 🇦🇺 AU | $2,3 Mrd. | D |
| 156 | Vericel Corporation US92346J1088 | 🇺🇸 US | $2,3 Mrd. | B+ |
| 157 | Nuvation Bio Inc. US67080N1019 | 🇺🇸 US | $2,2 Mrd. | D |
| 158 | Voronoi Inc. KR7310210000 | 🇰🇷 KR | $2,2 Mrd. | D |
| 159 | Jinyu Bio-technology Co. Ltd. CNE000000Y37 | 🇨🇳 CN | $2,2 Mrd. | D |
| 160 | Harmony Biosciences Holdings Inc. US4131971040 | 🇺🇸 US | $2,2 Mrd. | A+ |
| 161 | Bavarian Nordic A/S DK0015998017 | 🇩🇰 DK | $2,2 Mrd. | B |
| 162 | Palvella Therapeutics Inc. US6979471090 | 🇺🇸 US | $2,2 Mrd. | D |
| 163 | Anhui Anke Biotechnology (Group) Co. Ltd. CNE100000GY2 | 🇨🇳 CN | $2,2 Mrd. | C |
| 164 | Biohaven Ltd. VGG1110E1079 | 🇺🇸 US | $2,2 Mrd. | D |
| 165 | ADMA Biologics Inc. US0008991046 | 🇺🇸 US | $2,2 Mrd. | C |
| 166 | Duality Biotherapeutics Inc. KYG2929M1087 | 🇨🇳 CN | $2,1 Mrd. | D |
| 167 | Nanobiotix S.A. FR0011341205 | 🇫🇷 FR | $2,1 Mrd. | D |
| 168 | Neuren Pharmaceuticals Limited NZNEUE0001S8 | 🇦🇺 AU | $2,1 Mrd. | B+ |
| 169 | Nektar Therapeutics US6402683063 | 🇺🇸 US | $2,1 Mrd. | D |
| 170 | Genus plc GB0002074580 | 🇬🇧 GB | $2,0 Mrd. | C |
| 171 | SK bioscience Co.Ltd. KR7302440003 | 🇰🇷 KR | $2,0 Mrd. | D |
| 172 | GH Research PLC IE000GID8VI0 | 🇮🇪 IE | $2,0 Mrd. | D |
| 173 | Stoke Therapeutics Inc. US86150R1077 | 🇺🇸 US | $2,0 Mrd. | D |
| 174 | Agios Pharmaceuticals Inc. US00847X1046 | 🇺🇸 US | $2,0 Mrd. | D |
| 175 | Lakefront Biotherapeutics BE0003818359 | 🇧🇪 BE | $2,0 Mrd. | A |
| 176 | Septerna Inc US81734D1046 | 🇺🇸 US | $2,0 Mrd. | D |
| 177 | Aurinia Pharmaceuticals Inc. CA05156V1022 | 🇨🇦 CA | $2,0 Mrd. | A |
| 178 | Sarepta Therapeutics Inc. US8036071004 | 🇺🇸 US | $1,9 Mrd. | D |
| 179 | Damora Therapeutics Inc. KYG2646Y1044 | 🇺🇸 US | $1,9 Mrd. | D |
| 180 | Idorsia Ltd CH0363463438 | 🇨🇭 CH | $1,9 Mrd. | D |
| 181 | Taysha Gene Therapies Inc. US8776191061 | 🇺🇸 US | $1,9 Mrd. | D |
| 182 | Hugel Inc. KR7145020004 | 🇰🇷 KR | $1,9 Mrd. | C |
| 183 | Onesource Specialty Pharma Ltd. INE013P01021 | 🇮🇳 IN | $1,9 Mrd. | D |
| 184 | Zenas BioPharma Inc. US98937L1052 | 🇺🇸 US | $1,9 Mrd. | D |
| 185 | D&D Pharmatech KR7347850000 | 🇰🇷 KR | $1,9 Mrd. | D |
| 186 | COMPASS Pathways plc US20451W1018 | 🇬🇧 GB | $1,9 Mrd. | D |
| 187 | Zymeworks Inc. US98985Y1082 | 🇺🇸 US | $1,8 Mrd. | D |
| 188 | Immunocore Holdings plc US45258D1054 | 🇬🇧 GB | $1,8 Mrd. | D |
| 189 | AnaptysBio Inc. US0327241065 | 🇺🇸 US | $1,8 Mrd. | C |
| 190 | Syndax Pharmaceuticals Inc. US87164F1057 | 🇺🇸 US | $1,8 Mrd. | D |
| 191 | Xencor Inc. US98401F1057 | 🇺🇸 US | $1,7 Mrd. | D |
| 192 | Pharma Mar S.A. ES0169501022 | 🇪🇸 ES | $1,7 Mrd. | C |
| 193 | Intellia Therapeutics Inc. US45826J1051 | 🇺🇸 US | $1,7 Mrd. | D |
| 194 | Syngene International Limited INE398R01022 | 🇮🇳 IN | $1,7 Mrd. | C |
| 195 | Ascentage Pharma Group International KYG0519B1023 | 🇨🇳 CN | $1,7 Mrd. | D |
| 196 | Fortrea Holdings Inc. US34965K1079 | 🇺🇸 US | $1,7 Mrd. | D |
| 197 | Oxford Nanopore Technologies plc GB00BP6S8Z30 | 🇬🇧 GB | $1,6 Mrd. | D |
| 198 | Bicara Therapeutics Inc. Common Stock US0554771032 | 🇺🇸 US | $1,6 Mrd. | D |
| 199 | Recursion Pharmaceuticals Inc. US75629V1044 | 🇺🇸 US | $1,6 Mrd. | D |
| 200 | Concord Biotech Limited INE338H01029 | 🇮🇳 IN | $1,6 Mrd. | C |
| 201 | HBM Holdings Limited KYG4403H1002 | 🇨🇳 CN | $1,6 Mrd. | C |
| 202 | Forte Biosciences Inc. US34962G2084 | 🇺🇸 US | $1,6 Mrd. | D |
| 203 | Maravai LifeSciences Holdings Inc. US56600D1072 | 🇺🇸 US | $1,6 Mrd. | D |
| 204 | Absci Corporation US00091E1091 | 🇺🇸 US | $1,6 Mrd. | D |
| 205 | OliX PharmaceuticalsInc KR7226950004 | 🇰🇷 KR | $1,6 Mrd. | D |
| 206 | Vir Biotechnology Inc. US92764N1028 | 🇺🇸 US | $1,6 Mrd. | D |
| 207 | Innoviva Inc. US45781M1018 | 🇺🇸 US | $1,5 Mrd. | A |
| 208 | Maze Therapeutics Inc. US5787841007 | 🇺🇸 US | $1,5 Mrd. | D |
| 209 | Tyra Biosciences Inc. US90240B1061 | 🇺🇸 US | $1,5 Mrd. | D |
| 210 | Xeris Biopharma Holdings Inc. US98422E1038 | 🇺🇸 US | $1,5 Mrd. | C |
| 211 | Jade Biosciences Inc. US0080642061 | 🇺🇸 US | $1,4 Mrd. | D |
| 212 | Ascletis Pharma Inc. KYG0520K1094 | 🇨🇳 CN | $1,4 Mrd. | D |
| 213 | MoonLake Immunotherapeutics KY61559X1045 | 🇨🇭 CH | $1,4 Mrd. | D |
| 214 | ORIC Pharmaceuticals Inc. US68622P1093 | 🇺🇸 US | $1,4 Mrd. | D |
| 215 | ArriVent BioPharma Inc. US04272N1028 | 🇺🇸 US | $1,4 Mrd. | D |
| 216 | Inhibrx Biosciences Inc. US45720N1037 | 🇺🇸 US | $1,3 Mrd. | D |
| 217 | Novavax Inc. US6700024010 | 🇺🇸 US | $1,3 Mrd. | D |
| 218 | LB Pharmaceuticals Inc Common Stock US50180M1080 | 🇺🇸 US | $1,3 Mrd. | D |
| 219 | Monte Rosa Therapeutics Inc. US61225M1027 | 🇺🇸 US | $1,3 Mrd. | D |
| 220 | Everest Medicines Limited KYG3224E1061 | 🇨🇳 CN | $1,3 Mrd. | D |
| 221 | MeiraGTx Holdings plc KYG596651029 | 🇺🇸 US | $1,3 Mrd. | B+ |
| 222 | Cullinan Therapeutics Inc. US2300311063 | 🇺🇸 US | $1,3 Mrd. | D |
| 223 | Omeros Corporation US6821431029 | 🇺🇸 US | $1,3 Mrd. | B+ |
| 224 | Corvus Pharmaceuticals Inc. US2210151005 | 🇺🇸 US | $1,3 Mrd. | D |
| 225 | Vor Biopharma Inc. US9290332074 | 🇺🇸 US | $1,2 Mrd. | D |
| 226 | MannKind Corporation US56400P7069 | 🇺🇸 US | $1,2 Mrd. | D |
| 227 | Immatics N.V. NL0015285941 | 🇩🇪 DE | $1,2 Mrd. | D |
| 228 | EyePoint Pharmaceuticals Inc. US30233G2093 | 🇺🇸 US | $1,2 Mrd. | D |
| 229 | Replimune Group Inc. US76029N1063 | 🇺🇸 US | $1,2 Mrd. | D |
| 230 | Daan Gene Co. Ltd. CNE000001KP1 | 🇨🇳 CN | $1,2 Mrd. | D |
| 231 | Alto Neuroscience Inc. US02157Q1094 | 🇺🇸 US | $1,2 Mrd. | D |
| 232 | CStone Pharmaceuticals KYG2588M1006 | 🇨🇳 CN | $1,1 Mrd. | D |
| 233 | GNI Group Ltd. JP3386370005 | 🇯🇵 JP | $1,1 Mrd. | D |
| 234 | CanSino Biologics Inc. CNE100003F01 | 🇨🇳 CN | $1,1 Mrd. | D |
| 235 | Savara Inc. US8051111016 | 🇺🇸 US | $1,1 Mrd. | D |
| 236 | Wave Life Sciences Ltd. SG9999014716 | 🇸🇬 SG | $1,1 Mrd. | D |
| 237 | Avalo Therapeutics Inc. US05338F3064 | 🇺🇸 US | $1,0 Mrd. | D |
| 238 | CARsgen Therapeutics Holdings Limited KYG1996C1006 | 🇨🇳 CN | $1,0 Mrd. | D |
| 239 | Kuros Biosciences AG CH0325814116 | 🇨🇭 CH | $1,0 Mrd. | C |
| 240 | Lexicon Pharmaceuticals Inc. US5288723027 | 🇺🇸 US | $1,0 Mrd. | D |
| 241 | Lepu Biopharma Co. Ltd. CNE100004SM4 | 🇨🇳 CN | $1,0 Mrd. | D |
| 242 | Alphamab Oncology KYG0330A1013 | 🇨🇳 CN | $1,0 Mrd. | D |
| 243 | Sana Biotechnology Inc. US7995661045 | 🇺🇸 US | $1,0 Mrd. | D |
| 244 | MedinCell S.A. FR0004065605 | 🇫🇷 FR | $1,0 Mrd. | D |
| 245 | OPKO Health Inc. US68375N1037 | 🇺🇸 US | $1,0 Mrd. | D |
| 246 | Ardelyx Inc. US0396971071 | 🇺🇸 US | $1,0 Mrd. | D |
| 247 | Kura Oncology Inc. US50127T1097 | 🇺🇸 US | $1,0 Mrd. | D |
| 248 | Climb Bio Inc. US28658R1068 | 🇺🇸 US | $999 Mio. | D |
| 249 | Janux Therapeutics Inc. US47103J1051 | 🇺🇸 US | $992 Mio. | D |
| 250 | Orum Therapeutics Inc. KR7475830006 | 🇰🇷 KR | $976 Mio. | D |
| 251 | Abbisko Cayman Limited KYG0028A1085 | 🇨🇳 CN | $975 Mio. | D |
| 252 | Gubra A/S DK0062266474 | 🇩🇰 DK | $946 Mio. | A |
| 253 | Geron Corporation US3741631036 | 🇺🇸 US | $943 Mio. | D |
| 254 | Olema Pharmaceuticals Inc. US68062P1066 | 🇺🇸 US | $941 Mio. | D |
| 255 | Arbutus Biopharma Corp CA03879J1003 | 🇺🇸 US | $930 Mio. | C |
| 256 | Design Therapeutics Inc. US25056L1035 | 🇺🇸 US | $926 Mio. | D |
| 257 | Solid Biosciences Inc. US83422E2046 | 🇺🇸 US | $906 Mio. | D |
| 258 | Candel Therapeutics Inc. US1374041093 | 🇺🇸 US | $891 Mio. | D |
| 259 | PYC Therapeutics Limited AU000000PYC7 | 🇦🇺 AU | $887 Mio. | D |
| 260 | Theravance Biopharma Inc KYG8807B1068 | 🇺🇸 US | $880 Mio. | C |
| 261 | Annexon Inc. US03589W1027 | 🇺🇸 US | $841 Mio. | D |
| 262 | Pharming Group N.V. NL0010391025 | 🇳🇱 NL | $839 Mio. | D |
| 263 | PeptiDream Inc. JP3836750004 | 🇯🇵 JP | $833 Mio. | D |
| 264 | Basilea Pharmaceutica AG CH0011432447 | 🇨🇭 CH | $827 Mio. | C |
| 265 | Aclaris Therapeutics Inc. US00461U1051 | 🇺🇸 US | $827 Mio. | D |
| 266 | Oxford Biomedica plc GB00BDFBVT43 | 🇬🇧 GB | $808 Mio. | D |
| 267 | Aura Biosciences Inc. US05153U1079 | 🇺🇸 US | $794 Mio. | D |
| 268 | Rigel Pharmaceuticals Inc. US7665597024 | 🇺🇸 US | $785 Mio. | A+ |
| 269 | Monopar Therapeutics Inc. US61023L2079 | 🇺🇸 US | $780 Mio. | D |
| 270 | Achieve Life Sciences Inc. US0044685008 | 🇺🇸 US | $770 Mio. | D |
| 271 | Bright Minds Biosciences Inc. CA10919W4056 | 🇺🇸 US | $758 Mio. | D |
| 272 | Oculis Holding AG CH1242303498 | 🇨🇭 CH | $751 Mio. | D |
| 273 | Phathom Pharmaceuticals Inc. US71722W1071 | 🇺🇸 US | $751 Mio. | D |
| 274 | Gyre Therapeutics Inc. US4037831033 | 🇺🇸 US | $745 Mio. | D |
| 275 | CytomX Therapeutics Inc. US23284F1057 | 🇺🇸 US | $731 Mio. | D |
| 276 | Allogene Therapeutics Inc. US0197701065 | 🇺🇸 US | $718 Mio. | D |
| 277 | Oneness Biotech Co. Ltd. TW0004743000 | 🇹🇼 TW | $706 Mio. | D |
| 278 | Shattuck Labs Inc. US82024L1035 | 🇺🇸 US | $671 Mio. | D |
| 279 | Zevra Therapeutics Inc. US4884452065 | 🇺🇸 US | $669 Mio. | B |
| 280 | Valneva SE FR0004056851 | 🇫🇷 FR | $659 Mio. | D |
| 281 | Tectonic Therapeutic Inc. US8789721086 | 🇺🇸 US | $659 Mio. | D |
| 282 | Crescent Biopharma Inc. KYG2545C1042 | 🇺🇸 US | $649 Mio. | D |
| 283 | Nxera Pharma Co. Ltd. JP3431300007 | 🇯🇵 JP | $646 Mio. | D |
| 284 | 4D Molecular Therapeutics Inc. US35104E1001 | 🇺🇸 US | $637 Mio. | D |
| 285 | Immix Biopharma Inc. US45258H1068 | 🇺🇸 US | $617 Mio. | D |
| 286 | MiMedx Group Inc. US6024961012 | 🇺🇸 US | $611 Mio. | C |
| 287 | Chabiotech Co.Ltd. KR7085660009 | 🇰🇷 KR | $601 Mio. | D |
| 288 | Assembly Biosciences Inc. US0453962070 | 🇺🇸 US | $595 Mio. | D |
| 289 | Arvinas Inc. US04335A1051 | 🇺🇸 US | $594 Mio. | D |
| 290 | CorMedix Inc. US21900C3088 | 🇺🇸 US | $592 Mio. | C |
| 291 | REGENXBIO Inc. US75901B1070 | 🇺🇸 US | $586 Mio. | D |
| 292 | Altimmune Inc. US02155H2004 | 🇺🇸 US | $583 Mio. | D |
| 293 | Neurogene Inc. US64135M1053 | 🇺🇸 US | $580 Mio. | D |
| 294 | Verastem Inc. US92337C2035 | 🇺🇸 US | $578 Mio. | D |
| 295 | Artiva Biotherapeutics Inc. US04317A1079 | 🇺🇸 US | $574 Mio. | D |
| 296 | Prime Medicine Inc. US74168J1016 | 🇺🇸 US | $573 Mio. | D |
| 297 | ARS Pharmaceuticals Inc. US82835W1080 | 🇺🇸 US | $561 Mio. | D |
| 298 | OmniAb Inc. US68218J1034 | 🇺🇸 US | $554 Mio. | D |
| 299 | Ocumension Therapeutics KYG674111011 | 🇨🇳 CN | $548 Mio. | D |
| 300 | Kyverna Therapeutics Inc. US5019761049 | 🇺🇸 US | $544 Mio. | D |
| 301 | Ovid Therapeutics Inc. US6904691010 | 🇺🇸 US | $539 Mio. | D |
| 302 | Contineum Therapeutics Inc. US21217B1008 | 🇺🇸 US | $534 Mio. | D |
| 303 | Zura Bio Limited KYG9TY5A1016 | 🇺🇸 US | $526 Mio. | D |
| 304 | Hyundai Bioscience Co. Ltd. KR7048410005 | 🇰🇷 KR | $517 Mio. | D |
| 305 | Nuvectis Pharma Inc. US67080T1088 | 🇺🇸 US | $506 Mio. | D |
| 306 | Pharmicell Co. Ltd. KR7005690003 | 🇰🇷 KR | $504 Mio. | D |
| 307 | Relmada Therapeutics Inc. US75955J4022 | 🇺🇸 US | $500 Mio. | D |
| 308 | SanBio Company Limited JP3336750009 | 🇯🇵 JP | $500 Mio. | D |
| 309 | MapLight Therapeutics Inc. US56565P1030 | 🇺🇸 US | $477 Mio. | D |
| 310 | C4 Therapeutics Inc. US12529R1077 | 🇺🇸 US | $472 Mio. | D |
| 311 | Cabaletta Bio Inc. US12674W1099 | 🇺🇸 US | $471 Mio. | D |
| 312 | ProKidney Corp. US74291D1046 | 🇺🇸 US | $471 Mio. | D |
| 313 | Ocugen Inc. US67577C1053 | 🇺🇸 US | $466 Mio. | D |
| 314 | Prothena Corporation plc IE00B91XRN20 | 🇮🇪 IE | $465 Mio. | D |
| 315 | Lumosa Therapeutics Co. Ltd. TW0006535008 | 🇹🇼 TW | $452 Mio. | D |
| 316 | Rezolute Inc. US76200L3096 | 🇺🇸 US | $451 Mio. | D |
| 317 | Benitec Biopharma Inc. US08205P2092 | 🇺🇸 US | $449 Mio. | D |
| 318 | Puma Biotechnology Inc. US74587V1070 | 🇺🇸 US | $449 Mio. | C |
| 319 | Larimar Therapeutics Inc. US5171251003 | 🇺🇸 US | $449 Mio. | D |
| 320 | Fennec Pharmaceuticals Inc. CA31447P1009 | 🇺🇸 US | $444 Mio. | D |
| 321 | Ginkgo Bioworks Holdings Inc. US37611X2099 | 🇺🇸 US | $444 Mio. | D |
| 322 | Editas Medicine Inc. US28106W1036 | 🇺🇸 US | $433 Mio. | D |
| 323 | Capricor Therapeutics Inc. US14070B3096 | 🇺🇸 US | $428 Mio. | D |
| 324 | Atea Pharmaceuticals Inc. US04683R1068 | 🇺🇸 US | $418 Mio. | D |
| 325 | Compass Therapeutics Inc. US20454B1044 | 🇺🇸 US | $416 Mio. | D |
| 326 | X4 Pharmaceuticals Inc. US98420X2027 | 🇺🇸 US | $398 Mio. | D |
| 327 | GI Innovation Inc. KR7358570000 | 🇰🇷 KR | $395 Mio. | D |
| 328 | BioAge Labs Inc. US09077V1008 | 🇺🇸 US | $392 Mio. | D |
| 329 | Lexeo Therapeutics Inc. Common Stock US52886X1072 | 🇺🇸 US | $391 Mio. | D |
| 330 | Upstream Bio Inc. US91678A1079 | 🇺🇸 US | $385 Mio. | D |
| 331 | Enanta Pharmaceuticals Inc. US29251M1062 | 🇺🇸 US | $383 Mio. | D |
| 332 | Palisade Bio Inc. US6963894026 | 🇺🇸 US | $373 Mio. | D |
| 333 | Rocket Pharmaceuticals Inc. US77313F1066 | 🇺🇸 US | $371 Mio. | D |
| 334 | Foghorn Therapeutics Inc. US3441741077 | 🇺🇸 US | $368 Mio. | D |
| 335 | DiaMedica Therapeutics Inc. CA25253X2077 | 🇺🇸 US | $360 Mio. | D |
| 336 | Sagimet Biosciences Inc. US7867001049 | 🇺🇸 US | $344 Mio. | D |
| 337 | SAB Biotherapeutics Inc. US78397T2024 | 🇺🇸 US | $343 Mio. | D |
| 338 | Clinuvel Pharmaceuticals Limited AU000000CUV3 | 🇦🇺 AU | $340 Mio. | B |
| 339 | Medy-Tox Inc. KR7086900008 | 🇰🇷 KR | $340 Mio. | D |
| 340 | Abeona Therapeutics Inc. US00289Y2063 | 🇺🇸 US | $339 Mio. | D |
| 341 | Keros Therapeutics Inc. US4923271013 | 🇺🇸 US | $335 Mio. | D |
| 342 | Lyell Immunopharma Inc. US55083R2031 | 🇺🇸 US | $332 Mio. | D |
| 343 | GC Corp. KR7005250006 | 🇰🇷 KR | $324 Mio. | D |
| 344 | Prelude Therapeutics Incorporated US74065P1012 | 🇺🇸 US | $321 Mio. | D |
| 345 | Inhibikase Therapeutics Inc. US45719W2052 | 🇺🇸 US | $316 Mio. | D |
| 346 | Vanda Pharmaceuticals Inc. US9216591084 | 🇺🇸 US | $314 Mio. | D |
| 347 | Opus Genetics Inc. US67577R1023 | 🇺🇸 US | $301 Mio. | D |
| 348 | Fate Therapeutics Inc. US31189P1021 | 🇺🇸 US | $300 Mio. | D |
| 349 | Agenus Inc. US00847G8042 | 🇺🇸 US | $298 Mio. | D |
| 350 | Anavex Life Sciences Corp. US0327973006 | 🇺🇸 US | $297 Mio. | D |
| 351 | Sionna Therapeutics Inc. US8294011080 | 🇺🇸 US | $292 Mio. | D |
| 352 | Entrada Therapeutics Inc. US29384C1080 | 🇺🇸 US | $290 Mio. | D |
| 353 | Fulcrum Therapeutics Inc. US3596161097 | 🇺🇸 US | $285 Mio. | D |
| 354 | Inventiva S.A. US46124U1079 | 🇫🇷 FR | $283 Mio. | D |
| 355 | Orchestra BioMed Holdings Inc. US68572M1062 | 🇺🇸 US | $283 Mio. | D |
| 356 | Neumora Therapeutics Inc. Common Stock US6409791000 | 🇺🇸 US | $282 Mio. | D |
| 357 | Sol-Gel Technologies Ltd. IL0011417206 | 🇮🇱 IL | $277 Mio. | D |
| 358 | Eledon Pharmaceuticals Inc. US28617K1016 | 🇺🇸 US | $273 Mio. | D |
| 359 | Cartesian Therapeutics Inc. US8162123025 | 🇺🇸 US | $270 Mio. | D |
| 360 | PharmaEngine Inc. TW0004162003 | 🇹🇼 TW | $267 Mio. | C |
| 361 | ALX Oncology Holdings Inc. US00166B1052 | 🇺🇸 US | $265 Mio. | D |
| 362 | Lineage Cell Therapeutics Inc. US53566P1093 | 🇺🇸 US | $264 Mio. | D |
| 363 | MacroGenics Inc. US5560991094 | 🇺🇸 US | $258 Mio. | D |
| 364 | Whitehawk Therapeutics Inc US00032Q1040 | 🇺🇸 US | $254 Mio. | D |
| 365 | Zentalis Pharmaceuticals Inc. US98943L1070 | 🇺🇸 US | $253 Mio. | D |
| 366 | Greenwich LifeSciences Inc. US3968791083 | 🇺🇸 US | $247 Mio. | D |
| 367 | Niagen Bioscience Inc US1710774076 | 🇺🇸 US | $245 Mio. | D |
| 368 | Emergent BioSolutions Inc. US29089Q1058 | 🇺🇸 US | $237 Mio. | D |
| 369 | Arcturus Therapeutics Holdings Inc. US03969T1097 | 🇺🇸 US | $231 Mio. | D |
| 370 | Akebia Therapeutics Inc. US00972D1054 | 🇺🇸 US | $231 Mio. | D |
| 371 | Adimmune Corporation TW0004142005 | 🇹🇼 TW | $228 Mio. | D |
| 372 | Alector Inc. US0144421072 | 🇺🇸 US | $228 Mio. | D |
| 373 | Galectin Therapeutics Inc. US3632252025 | 🇺🇸 US | $227 Mio. | D |
| 374 | Protara Therapeutics Inc. US74365U1079 | 🇺🇸 US | $223 Mio. | D |
| 375 | Compugen Ltd. IL0010852080 | 🇮🇱 IL | $222 Mio. | B |
| 376 | AN2 Therapeutics Inc. US0373261058 | 🇺🇸 US | $206 Mio. | D |
| 377 | Minerva Neurosciences Inc. US6033802058 | 🇺🇸 US | $206 Mio. | D |
| 378 | Tonix Pharmaceuticals Holding Corp. US8902608392 | 🇺🇸 US | $203 Mio. | D |
| 379 | Sutro Biopharma Inc. US8693672011 | 🇺🇸 US | $198 Mio. | D |
| 380 | Voyager Therapeutics Inc. US92915B1061 | 🇺🇸 US | $198 Mio. | D |
| 381 | Acumen Pharmaceuticals Inc. US00509G2093 | 🇺🇸 US | $192 Mio. | D |
| 382 | Immuneering Corporation US45254E1073 | 🇺🇸 US | $189 Mio. | D |
| 383 | Oramed Pharmaceuticals Inc. US68403P2039 | 🇺🇸 US | $187 Mio. | D |
| 384 | Corbus Pharmaceuticals Holdings Inc. US21833P3010 | 🇺🇸 US | $187 Mio. | D |
| 385 | Protalix BioTherapeutics Inc. US74365A3095 | 🇺🇸 US | $185 Mio. | D |
| 386 | Surrozen Inc. US86889P2083 | 🇺🇸 US | $179 Mio. | D |
| 387 | Coherus Oncology Inc. US19249H1032 | 🇺🇸 US | $178 Mio. | D |
| 388 | Nkarta Inc. US65487U1088 | 🇺🇸 US | $174 Mio. | D |
| 389 | MediWound Ltd. IL0011316309 | 🇮🇱 IL | $172 Mio. | D |
| 390 | Codexis Inc. US1920051067 | 🇺🇸 US | $171 Mio. | D |
| 391 | Century Therapeutics Inc. US15673T1007 | 🇺🇸 US | $169 Mio. | D |
| 392 | OnKure Therapeutics Inc. US68277Q1058 | 🇺🇸 US | $166 Mio. | D |
| 393 | Caribou Biosciences Inc. US1420381089 | 🇺🇸 US | $157 Mio. | D |
| 394 | Canton Strategic Holdings Inc US4327053090 | 🇺🇸 US | $156 Mio. | D |
| 395 | BINEX Co. Ltd. KR7053030003 | 🇰🇷 KR | $156 Mio. | D |
| 396 | LENZ Therapeutics Inc. US52635N1037 | 🇺🇸 US | $150 Mio. | D |
| 397 | Quantum-Si incorporated US74765K1051 | 🇺🇸 US | $147 Mio. | D |
| 398 | Unicycive Therapeutics Inc. US90466Y2028 | 🇺🇸 US | $147 Mio. | D |
| 399 | Spruce Biosciences Inc. US85209E2081 | 🇺🇸 US | $145 Mio. | D |
| 400 | Tharimmune Inc. US4327053090 | 🇺🇸 US | $140 Mio. | D |
| 401 | ADC Therapeutics S.A. CH0499880968 | 🇨🇭 CH | $140 Mio. | D |
| 402 | Milestone Pharmaceuticals Inc. CA59935V1076 | 🇨🇦 CA | $137 Mio. | D |
| 403 | Korro Bio Inc. US5009461089 | 🇺🇸 US | $131 Mio. | D |
| 404 | Black Diamond Therapeutics Inc. US09203E1055 | 🇺🇸 US | $117 Mio. | D |
| 405 | Onconic Therapeutics KR7476060009 | 🇰🇷 KR | $114 Mio. | D |
| 406 | Nautilus Biotechnolgy Inc. US63909J1088 | 🇺🇸 US | $112 Mio. | D |
| 407 | CAMP4 Therapeutics Corporation US13463J1016 | 🇺🇸 US | $106 Mio. | D |
| 408 | Precision BioSciences Inc. US74019P2074 | 🇺🇸 US | $95 Mio. | D |
| 409 | Cue Biopharma Inc. US22978P2056 | 🇺🇸 US | $80 Mio. | D |
| 410 | Heron Therapeutics Inc. US4277461020 | 🇺🇸 US | $61 Mio. | D |
| 411 | NRx Pharmaceuticals Inc. US6294442099 | 🇺🇸 US | $59 Mio. | D |
| 412 | Tenax Therapeutics Inc. US88032L6056 | 🇺🇸 US | $48 Mio. | D |
| 413 | Aligos Therapeutics Inc. US01626L2043 | 🇺🇸 US | $43 Mio. | D |
| 414 | Karyopharm Therapeutics Inc. US48576U2050 | 🇺🇸 US | $41 Mio. | D |
| 415 | Coeptis Therapeutics Holdings Inc. US98878K1088 | 🇺🇸 US | $39 Mio. | D |
| 416 | CervoMed Inc. US15713L1098 | 🇺🇸 US | $28 Mio. | D |
| 417 | Quantum BioPharma Ltd. CA74764Y2050 | 🇨🇦 CA | $24 Mio. | D |
| 418 | Neuphoria Therapeutics Inc. US64136E1029 | 🇺🇸 US | $21 Mio. | D |